Home > National Drug Code (NDC) > Xopenex HFA

Xopenex HFA - 63402-510-01 - (levalbuterol tartrate)

Alphabetical Index


Drug Information of Xopenex HFA

Product NDC: 63402-510
Proprietary Name: Xopenex HFA
Non Proprietary Name: levalbuterol tartrate
Active Ingredient(s): 45    ug/1 & nbsp;   levalbuterol tartrate
Administration Route(s): ORAL
Dosage Form(s): AEROSOL, METERED
Coding System: National Drug Codes(NDC)

Labeler Information of Xopenex HFA

Product NDC: 63402-510
Labeler Name: Sunovion Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021730
Marketing Category: NDA
Start Marketing Date: 20051201

Package Information of Xopenex HFA

Package NDC: 63402-510-01
Package Description: 1 INHALER in 1 CARTON (63402-510-01) > 200 AEROSOL, METERED in 1 INHALER

NDC Information of Xopenex HFA

NDC Code 63402-510-01
Proprietary Name Xopenex HFA
Package Description 1 INHALER in 1 CARTON (63402-510-01) > 200 AEROSOL, METERED in 1 INHALER
Product NDC 63402-510
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name levalbuterol tartrate
Dosage Form Name AEROSOL, METERED
Route Name ORAL
Start Marketing Date 20051201
Marketing Category Name NDA
Labeler Name Sunovion Pharmaceuticals Inc.
Substance Name LEVALBUTEROL TARTRATE
Strength Number 45
Strength Unit ug/1
Pharmaceutical Classes Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]

Complete Information of Xopenex HFA


General Information